David Li
Stock Analyst at Bank of America Securities
(2.03)
# 3,195
Out of 4,592 analysts
100
Total ratings
48%
Success rate
0.9%
Average return
Main Sectors:
Stocks Rated by David Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZLAB Zai Lab | Maintained: Hold | $22 → $22 | $18.27 | +18.23% | 41 | May 21, 2026 | |
| HKG: 6160 BeOne Medicines AG | Maintained: Buy | $243.80 | $194.00 | +25.67% | 1 | May 21, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $350 → $402 | $316.01 | +27.27% | 34 | Nov 7, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Buy | $38.00 → $56.00 | $37.72 | +48.46% | 2 | Aug 29, 2025 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $56.90 | $86.70 | n/a | 1 | Jan 3, 2025 | |
| HKG: 2607 Shanghai Pharmaceuticals Holding Co., Ltd | Maintained: Buy | $15.70 | $12.02 | n/a | 1 | Jan 3, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Upgraded: Buy | $20.80 | $32.18 | n/a | 1 | Jun 7, 2024 | |
| BNR Burning Rock Biotech | Reiterated: Buy | $8.9 → $73 | $8.90 | n/a | 4 | Sep 1, 2023 | |
| NBP NovaBridge Biosciences | Maintained: Buy | $77 → $65 | $1.60 | n/a | 2 | Aug 31, 2022 | |
| HKG: 1530 3SBio Inc. | Maintained: Buy | $11.87 | $16.72 | n/a | 2 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.03 | n/a | 5 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.58 | n/a | 2 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.82 | n/a | 1 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.76 → $0.65 | $15.14 | n/a | 2 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.34 | $2.33 | n/a | 1 | Jun 13, 2019 |
Zai Lab
May 21, 2026
Maintained: Hold
Price Target: $22 → $22
Current: $18.27
Upside: +18.23%
BeOne Medicines AG
May 21, 2026
Maintained: Buy
Price Target: $243.80
Current: $194.00
Upside: +25.67%
BeOne Medicines AG
Nov 7, 2025
Reiterated: Buy
Price Target: $350 → $402
Current: $316.01
Upside: +27.27%
Hangzhou Tigermed Consulting Co., Ltd
Aug 29, 2025
Maintained: Buy
Price Target: $38.00 → $56.00
Current: $37.72
Upside: +48.46%
Innovent Biologics, Inc.
Jan 3, 2025
Maintained: Buy
Price Target: $56.90
Current: $86.70
Upside: n/a
Shanghai Pharmaceuticals Holding Co., Ltd
Jan 3, 2025
Maintained: Buy
Price Target: $15.70
Current: $12.02
Upside: n/a
Hansoh Pharmaceutical Group Company Limited
Jun 7, 2024
Upgraded: Buy
Price Target: $20.80
Current: $32.18
Upside: n/a
Burning Rock Biotech
Sep 1, 2023
Reiterated: Buy
Price Target: $8.9 → $73
Current: $8.90
Upside: n/a
NovaBridge Biosciences
Aug 31, 2022
Maintained: Buy
Price Target: $77 → $65
Current: $1.60
Upside: n/a
3SBio Inc.
Dec 29, 2020
Maintained: Buy
Price Target: $11.87
Current: $16.72
Upside: n/a
Jul 30, 2020
Maintained: Buy
Price Target: n/a
Current: $5.03
Upside: n/a
Jul 30, 2020
Maintained: Buy
Price Target: n/a
Current: $8.58
Upside: n/a
Jul 30, 2020
Maintained: Buy
Price Target: n/a
Current: $7.82
Upside: n/a
Apr 3, 2020
Maintained: Sell
Price Target: $1.76 → $0.65
Current: $15.14
Upside: n/a
Jun 13, 2019
Maintained: Buy
Price Target: $10.34
Current: $2.33
Upside: n/a